A supplier that documents what it ships
Apex Peptide Labs supplies research-grade peptides in lyophilised vial format to distributors, laboratories and private-label buyers. The catalogue is deliberately narrow: 87 families we can hold in stock, rather than a list of everything that can theoretically be synthesised.
How the plant is organised
Compounding, filling, lyophilisation and inspection run as four separate steps under one batch record. A lot cannot move to the next step until the previous step's record is signed, which is why we can tell a buyer which tray, which run and which analyst produced the vial in their hand.
Blends are compounded before fill rather than mixed after drying. That single decision means a three-peptide blend arrives as one homogeneous cake instead of a stack of plugs that separate when the vial is inverted.
What we do not do
We do not sell finished medicines, we do not advise on human dosing, and we do not print claims on a label that we cannot support with a test result. Buyers who need regulatory guidance for their own market should take it from their own counsel — we will supply the documents, not the interpretation.
Capacity and lead time
Stock specifications ship from held inventory. Custom fills and private-label artwork require a pilot lot, and the pilot is retained as the reference standard for every later batch of that SKU. Lead times are stated on the quotation rather than on this page, because they depend on the fill and the destination.
Research use only. Not for human or veterinary use.
At a glance
Start here
The price list carries every stock fill. If the strength you need is not listed, it is a custom fill.
Open the price list